Rotavirus vaccines: a long and difficult journey
Diarrhea is the second cause of death worldwide. The main causative agent in infants and children less than 5 years is rotavirus. Consequently, for the World Health Organization and the Global Alliance for Vaccines and Immunization (GAVI), rotavirus vaccination is an urgent priority. The global dist...
Gespeichert in:
Veröffentlicht in: | Gastroenterología y hepatología 2011-12, Vol.34 (10), p.694-700 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | spa |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 700 |
---|---|
container_issue | 10 |
container_start_page | 694 |
container_title | Gastroenterología y hepatología |
container_volume | 34 |
creator | Campins Martí, Magda Moraga-Llop, Fernando A |
description | Diarrhea is the second cause of death worldwide. The main causative agent in infants and children less than 5 years is rotavirus. Consequently, for the World Health Organization and the Global Alliance for Vaccines and Immunization (GAVI), rotavirus vaccination is an urgent priority. The global distribution of rotavirus serotypes varies from country to country, but in 80-90% of cases is caused by five types: G1P[8], G2P[4], G3P[8], G4P[8] and G9P[8]. Currently, two rotavirus vaccines are available, an attenuated monovalent G1P[8] vaccine, and a pentavalent human-bovine recombinant vaccine containing five strains of bovine WC3 rotavirus, four with a gene codifying the VP7 protein of human rotaviruses G1, G2, G3 and G4, and a fifth expressing the VP4 P[8] genotype. |
doi_str_mv | 10.1016/j.gastrohep.2011.09.003 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_909292656</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>909292656</sourcerecordid><originalsourceid>FETCH-LOGICAL-p140t-4867d775e64619c0d4310947b69e5040a1f97292c872db5984cfbae9fd0f28563</originalsourceid><addsrcrecordid>eNo1j8tKw0AYRmeh2Fp9BZ2dq8R_7hl3UrxBQRBdh8lc6oQ0EzNJoW-vaF2dzTkffAhdEygJEHnblluTpzF9-qGkQEgJugRgJ2gJlEAhFIgFOs-5BaCCUX2GFpQSQiXjSwRvaTL7OM4Z7421sff5DhvcpX6LTe-wiyFEO3cTbtM89v5wgU6D6bK_PHKFPh4f3tfPxeb16WV9vykGwmEqeCWVU0p4ySXRFhxnBDRXjdReAAdDglZUU1sp6hqhK25DY7wODgKthGQrdPO3O4zpa_Z5qncxW991pvdpzrUG_ZPLX_PqaM7Nzrt6GOPOjIf6_yT7BqA7Uyg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>909292656</pqid></control><display><type>article</type><title>Rotavirus vaccines: a long and difficult journey</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Campins Martí, Magda ; Moraga-Llop, Fernando A</creator><creatorcontrib>Campins Martí, Magda ; Moraga-Llop, Fernando A</creatorcontrib><description>Diarrhea is the second cause of death worldwide. The main causative agent in infants and children less than 5 years is rotavirus. Consequently, for the World Health Organization and the Global Alliance for Vaccines and Immunization (GAVI), rotavirus vaccination is an urgent priority. The global distribution of rotavirus serotypes varies from country to country, but in 80-90% of cases is caused by five types: G1P[8], G2P[4], G3P[8], G4P[8] and G9P[8]. Currently, two rotavirus vaccines are available, an attenuated monovalent G1P[8] vaccine, and a pentavalent human-bovine recombinant vaccine containing five strains of bovine WC3 rotavirus, four with a gene codifying the VP7 protein of human rotaviruses G1, G2, G3 and G4, and a fifth expressing the VP4 P[8] genotype.</description><identifier>ISSN: 0210-5705</identifier><identifier>DOI: 10.1016/j.gastrohep.2011.09.003</identifier><identifier>PMID: 22112634</identifier><language>spa</language><publisher>Spain</publisher><subject>Diarrhea - prevention & control ; Diarrhea - virology ; Humans ; Rotavirus Infections - prevention & control ; Rotavirus Vaccines - adverse effects ; Rotavirus Vaccines - immunology</subject><ispartof>Gastroenterología y hepatología, 2011-12, Vol.34 (10), p.694-700</ispartof><rights>Copyright © 2011 Elsevier España, S.L. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22112634$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Campins Martí, Magda</creatorcontrib><creatorcontrib>Moraga-Llop, Fernando A</creatorcontrib><title>Rotavirus vaccines: a long and difficult journey</title><title>Gastroenterología y hepatología</title><addtitle>Gastroenterol Hepatol</addtitle><description>Diarrhea is the second cause of death worldwide. The main causative agent in infants and children less than 5 years is rotavirus. Consequently, for the World Health Organization and the Global Alliance for Vaccines and Immunization (GAVI), rotavirus vaccination is an urgent priority. The global distribution of rotavirus serotypes varies from country to country, but in 80-90% of cases is caused by five types: G1P[8], G2P[4], G3P[8], G4P[8] and G9P[8]. Currently, two rotavirus vaccines are available, an attenuated monovalent G1P[8] vaccine, and a pentavalent human-bovine recombinant vaccine containing five strains of bovine WC3 rotavirus, four with a gene codifying the VP7 protein of human rotaviruses G1, G2, G3 and G4, and a fifth expressing the VP4 P[8] genotype.</description><subject>Diarrhea - prevention & control</subject><subject>Diarrhea - virology</subject><subject>Humans</subject><subject>Rotavirus Infections - prevention & control</subject><subject>Rotavirus Vaccines - adverse effects</subject><subject>Rotavirus Vaccines - immunology</subject><issn>0210-5705</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j8tKw0AYRmeh2Fp9BZ2dq8R_7hl3UrxBQRBdh8lc6oQ0EzNJoW-vaF2dzTkffAhdEygJEHnblluTpzF9-qGkQEgJugRgJ2gJlEAhFIgFOs-5BaCCUX2GFpQSQiXjSwRvaTL7OM4Z7421sff5DhvcpX6LTe-wiyFEO3cTbtM89v5wgU6D6bK_PHKFPh4f3tfPxeb16WV9vykGwmEqeCWVU0p4ySXRFhxnBDRXjdReAAdDglZUU1sp6hqhK25DY7wODgKthGQrdPO3O4zpa_Z5qncxW991pvdpzrUG_ZPLX_PqaM7Nzrt6GOPOjIf6_yT7BqA7Uyg</recordid><startdate>201112</startdate><enddate>201112</enddate><creator>Campins Martí, Magda</creator><creator>Moraga-Llop, Fernando A</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201112</creationdate><title>Rotavirus vaccines: a long and difficult journey</title><author>Campins Martí, Magda ; Moraga-Llop, Fernando A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p140t-4867d775e64619c0d4310947b69e5040a1f97292c872db5984cfbae9fd0f28563</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>spa</language><creationdate>2011</creationdate><topic>Diarrhea - prevention & control</topic><topic>Diarrhea - virology</topic><topic>Humans</topic><topic>Rotavirus Infections - prevention & control</topic><topic>Rotavirus Vaccines - adverse effects</topic><topic>Rotavirus Vaccines - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Campins Martí, Magda</creatorcontrib><creatorcontrib>Moraga-Llop, Fernando A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Gastroenterología y hepatología</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Campins Martí, Magda</au><au>Moraga-Llop, Fernando A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Rotavirus vaccines: a long and difficult journey</atitle><jtitle>Gastroenterología y hepatología</jtitle><addtitle>Gastroenterol Hepatol</addtitle><date>2011-12</date><risdate>2011</risdate><volume>34</volume><issue>10</issue><spage>694</spage><epage>700</epage><pages>694-700</pages><issn>0210-5705</issn><abstract>Diarrhea is the second cause of death worldwide. The main causative agent in infants and children less than 5 years is rotavirus. Consequently, for the World Health Organization and the Global Alliance for Vaccines and Immunization (GAVI), rotavirus vaccination is an urgent priority. The global distribution of rotavirus serotypes varies from country to country, but in 80-90% of cases is caused by five types: G1P[8], G2P[4], G3P[8], G4P[8] and G9P[8]. Currently, two rotavirus vaccines are available, an attenuated monovalent G1P[8] vaccine, and a pentavalent human-bovine recombinant vaccine containing five strains of bovine WC3 rotavirus, four with a gene codifying the VP7 protein of human rotaviruses G1, G2, G3 and G4, and a fifth expressing the VP4 P[8] genotype.</abstract><cop>Spain</cop><pmid>22112634</pmid><doi>10.1016/j.gastrohep.2011.09.003</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0210-5705 |
ispartof | Gastroenterología y hepatología, 2011-12, Vol.34 (10), p.694-700 |
issn | 0210-5705 |
language | spa |
recordid | cdi_proquest_miscellaneous_909292656 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Diarrhea - prevention & control Diarrhea - virology Humans Rotavirus Infections - prevention & control Rotavirus Vaccines - adverse effects Rotavirus Vaccines - immunology |
title | Rotavirus vaccines: a long and difficult journey |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T08%3A18%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Rotavirus%20vaccines:%20a%20long%20and%20difficult%20journey&rft.jtitle=Gastroenterolog%C3%ADa%20y%20hepatolog%C3%ADa&rft.au=Campins%20Mart%C3%AD,%20Magda&rft.date=2011-12&rft.volume=34&rft.issue=10&rft.spage=694&rft.epage=700&rft.pages=694-700&rft.issn=0210-5705&rft_id=info:doi/10.1016/j.gastrohep.2011.09.003&rft_dat=%3Cproquest_pubme%3E909292656%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=909292656&rft_id=info:pmid/22112634&rfr_iscdi=true |